FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer. (2020)

First Author: Annett S
Attributed to:  Confidence in Concept 2012 - Queen's University Belfast funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-019-0649-5

PubMed Identifier: 31772325

Publication URI: http://europepmc.org/abstract/MED/31772325

Type: Journal Article/Review

Volume: 122

Parent Publication: British journal of cancer

Issue: 3

ISSN: 0007-0920